Phototherapy Lamps Market Report

In the year 2022, LED phototherapy lamps dominated the product segment. The increased prevalence of such skin disorders is projected to drive the adoption of LED-based phototherapy lamps. In accordance with Yale Medicine, 85% of people suffer from acne at some time in their lives. Acne is the most prevalent skin disorder in the United States, impacting up to 50 million Americans annually, according to the American Academy of Dermatology Association. The growing number of persons with fine lines and wrinkles is projected to help the market grow. Massage Envy commissioned the survey, which interviewed 2,000 Americans about the things that make them self-conscious about their appearance. According to the poll, 59 % of people are not comfortable in their own skin. This could boost the adoption of LED-based phototherapy lamps, driving segment growth throughout the forecast period. Traditional phototherapy lamps are used to treat jaundice since it reduces bilirubin levels in new-borns. The increased frequency of neonates with jaundice is expected to boost the segment throughout the forecast period. According to the March of Dimes, approximately three out of every five new-borns account for 60% suffer from jaundice. Similarly, according to Medscape, 80% of pre-term newborns are likely to develop jaundice during the first 2-4 days. As a result, the growing number of pre-terms new-borns is expected to aid the segment's growth.

Phototherapy may have drawbacks even if it is a helpful treatment option in dermatology. Short- and long-term adverse effects with varied degrees of severity include pruritus, photoaging, xerosis, blistering, skin erythema, photo carcinogenesis and altered pigmentation. Photoprotective strategies such as limiting concurrent sun exposure and covering skin parts not affected by disease, as well as more sophisticated approaches such as exogenous DNA repair enzymes and phytochemical antioxidants may reduce the risks of phototherapy. These factors are limiting the global phototherapy lamps market's growth. Furthermore, worries regarding safety and the necessity for diligent supervision during treatment may raise the complexity and expenses, ultimately restricting market expansion. With an increasing understanding of these dangers, the use of phototherapy lamps is being questioned, emphasizing the importance of enhancing safety tactics and educating patients to reduce negative outcomes.

The introduction of new products and innovation is greatly increasing market growth by bringing in upgraded features and enhanced functionality. These advancements improve how products function and meet changing consumer demands, opening up fresh market possibilities. Innovative solutions frequently result in enhanced effectiveness, improved user satisfaction, and expanded usage, ultimately driving market growth and creating competitive edges for companies. For instance, STRATA Skin Sciences, Inc. announced the commercial introduction of their next-generation excimer laser system, XTRAC Momentum 1.0, in February 2022. For both adult and paediatric patients suffering from inflammatory skin disorders such as atopic dermatitis, psoriasis and vitiligo the XTRAC excimer laser technology enables for precise application of specific UVB light therapy to particular therapeutic areas of the skin. Additionally, In June 2022, LightStim introduced LightElipsaTM, its most recent advancement in LED light therapy, which works in integration with Syndeo, BeautyHealth's upcoming HydraFacial device.

The increasing number of dermatological disorders such as psoriasis, the availability of advanced medical technologies, rising healthcare spending and the presence of some of the major players are driving growth in the U.S. phototherapy lamps market. Over the past few years, there has been a significant increase in psoriasis cases in the United States and other North American countries, fuelling demand for therapies such as phototherapy. As per the National Psoriasis Foundation, psoriasis affects more than 3% of the adult population in the United States. This equals to more than 7.5 million US adults. In accordance to the Canadian Dermatology Association, acne affects about 5.6 million individuals in Canada, accounting for 20% of the overall population. Similarly, according to the most recent Atopic Dermatitis in America estimates, around 7.3% of U.S. adults suffer with eczema, with approximately 40% experiencing moderate to severe symptoms. This will offer a significant boost to the country's phototherapy lamps market. Furthermore, rising aesthetics awareness and increasing adoption of cosmetic procedures are likely to drive expansion in the country's total phototherapy lamps market throughout the forecast period.